Elevance Health Q2 Earnings Preview: Will Q2 Earnings Rebound?

Source and reference

source on Google Add Now Elevance Health, Inc. ( ELV ) is scheduled to report its second-quarter results today (Wednesday, July 15, 2026). Elevance, together with its subsidiaries, operates as a health benefits company. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company's net income for the first quarter of 2026 slipped 19.2% to $1.76 billion, or $8.00 per share, compared with $2.18 billion, or $9.61 per share, in the prior year. For the first quarter of 2026, the company recorded a total revenue of $50.18 billion, up 2.6% from $48.89 billion in the year-ago. Revenue from premiums jumped 0.3% to $41.02 billion from $40.89 billion in the prior year. Product revenue increased 7.2% to $6.22 billion from $5.81 billion a year ago. Service fees revenue rose 8.5% to $2.25 billion from $2.07 billion a year ago. The...